Febuxostat

Details

Files

Generic Name:

Febuxostat

Project Status:

Complete

Therapeutic Area:

Gout

Manufacturer:

Takeda Canada Inc.

Call for patient/clinician input open:

September 30, 2010

Brand Name:

Uloric

Project Line:

Reimbursement Review

Project Number:

SR0213-000

Call for patient/clinician input closed:

November 17, 2010

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Gout

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

April 25, 2011

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Plain Language Recommendation View PDF

Last Updated : October 27, 2010